Home - Products - Others - Other Targets - [Leu144] - PLP (139 - 151), L144 - PLP(139 - 151)

[Leu144] - PLP (139 - 151), L144 - PLP(139 - 151)

CAS No. ———

[Leu144] - PLP (139 - 151), L144 - PLP(139 - 151)( ——— )

Catalog No. M41506 CAS No. ———

[Leu144] - PLP (139 - 151), L144 - PLP(139 - 151)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Leu144] - PLP (139 - 151), L144 - PLP(139 - 151)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Leu144] - PLP (139 - 151), L144 - PLP(139 - 151)
  • Description
    [Leu144] - PLP (139 - 151), L144 - PLP(139 - 151)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1448.7
  • Molecular Formula
    C67H105N19O17
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3-Acetylcoumarin

    3-Acetylcoumarin as a practical ligand for copper-catalyzed CN coupling reactions at room temperature. It?has neuroprotective and acaricidal properties.

  • Aschantin

    Aschantin, a bisepoxylignan, can be isolated from Magnolia biondii. Aschantin has antiplasmodial, Ca2+-antagonistic, platelet activating factor-antagonistic, and chemopreventive activities. Aschantin is a mTOR kinase inhibitor. Aschantin is also an inhibitor of Cytochrome P450 and UGT enzyme.

  • Marstenacisside F1

    Marstenacisside F1 (compound 1) is a polyoxypregnanoside with anti-inflammatory activity isolated from Marsdenia tenacissima. Marstenacisside F1 inhibits lipopolysaccharide-induced nitric oxide (NO) production in RAW 264.7 cells and is a derivative of Tenacigenin B.